The Science of Cancer Health Equity for Sexual and Gender Minority Communities

性和性别少数群体的癌症健康公平科学

• 批准号: 10749970
• 负责人: Charles Stewart Kamen
• 金额: $ 3.25万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-22 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10749970
• 关键词: Address; American Cancer Society; Area; Attention; Award; Awareness; Back; Cancer Center; Cancer Control; Cancer Patient; Cancer Science; Cancer Survivorship; Cancer health equity; Caregivers; Collaborations; Communities; Community Actions; Complex; Consensus; Data; Data Collection; Diagnosis; Disparity; Epidemiology; Fees; Funding; Future; Gender Identity; Geography; Health; Individual; Infrastructure; Intervention; Lesbian Gay Bisexual Transgender; Lesbian Gay Bisexual Transgender Intersex; Level of Evidence; Los Angeles; Malignant Neoplasms; Medical center; Mentorship; Minority; Modeling; Modification; Names; National Cancer Institute; National Institute on Minority Health and Health Disparities; New York; New York City; Participant; Patients; Peer Review; Persons; Policies; Population; Populations at Risk; Professional Organizations; Publications; Recording of previous events; Research; Research Methodology; Research Personnel; Research Priority; Risk Factors; Safety; Science; Scientist; Screening for cancer; Sex Orientation; Sexual and Gender Minorities; Structure; Survivors; Techniques; Training; Travel; United States National Institutes of Health; Universities; Work; anticancer research; cancer diagnosis; cancer health disparity; cancer prevention; cancer risk; community engagement; community organizations; cost; disparity reduction; experience; gender minority community; gender minority group; innovation; interest; intersectionality; lifetime risk; meetings; member; minority stress; novel; novel strategies; posters; social; symposium; transgender

ABSTRACT Sexual and gender minority people (SGM) experience multiple cancer-related disparities, including higher rates of cancer risk factors, lower rates of cancer screening, higher lifetime risk of cancer, and unmet needs during cancer survivorship. Although many national organizations, including the National Cancer Institute (NCI) and the American Cancer Society (ACS), have stated the need for more cancer research among SGM communities, there is currently no consensus about the highest research priorities, promising research models, or mechanisms for collaboration between geographically dispersed scientific teams. To address this gap, we propose a two-and- a-half day conference focused on the “Science of Cancer Health Equity for SGM Communities.” This conference will bring together researchers, trainees, early-stage investigators, and community stakeholders to review the current science on cancer health equity for SGM persons, identify high-priority research topics, and develop novel approaches to engage communities and influence policy. The conference will be held at the New York University (NYU) Langone Medical Center Campus in New York City from October 5-7, 2023. It is structured around a transdisciplinary framework: looking within, across, and between areas of scientific expertise and community wisdom to establish priorities. In line with this framework, we have convened a conference organizing committee comprising two MPIs, representatives from 7 cancer centers, and a SGM Community Action Board, with strong support from SGM community organizations such as the National LGBT Cancer Network. Support from the NCI R13 mechanism (PA-21-151) is needed to cover speaker fees as well as travel costs for trainees, early-stage investigators, patients and community participants. The aims of this conference are: 1) to examine the current level of evidence informing research across the cancer control continuum for SGM cancer patients, survivors, and caregivers; 2) to establish future research priorities across the cancer control continuum for SGM cancer patients, survivors, and caregivers; 3) to promote the research of trainees and early stage investigators, especially those from minoritized backgrounds, interested in research across the cancer control continuum for SGM communities; 4) to develop a transdisciplinary network of scholars with a focus on mentorship and on shared research methods that can address cancer health equity across the cancer control continuum; 5) to disseminate findings from this conference, including priorities for future SGM cancer health equity research, through a publicly available executive summary and a peer-reviewed, open access publication. If funded, this conference will produce: (a) a publicized list of SGM cancer health equity research priorities and (b) a network of transdisciplinary researchers and community members ready to collaborate on projects addressing these priorities. This R13 award will also help us create an infrastructure for future conferences to continue this work, with the next hosted by Cedars Sinai in Los Angeles in 2024.

摘要 性和性别少数人群（SGM）经历多种癌症相关的差异，包括更高的发病率 癌症风险因素，癌症筛查率较低，癌症的终身风险较高，以及 癌症存活率尽管许多国家组织，包括国家癌症研究所（NCI）和 美国癌症协会（ACS）表示，需要在SGM社区进行更多的癌症研究， 目前还没有就最高的研究优先级、有前途的研究模式或机制达成共识 地理上分散的科学团队之间的合作。为了弥补这一差距，我们提出了一个两个和- 为期半天的会议集中在“癌症健康公平的科学为SGM社区。”这 会议将汇集研究人员，学员，早期调查人员和社区利益相关者， 审查SGM人员癌症健康公平性的当前科学，确定高度优先的研究课题， 制定新的方法，让社区参与并影响政策。会议将在新 约克大学（NYU）Langone医学中心校园在纽约市从2023年10月5日至7日。它的结构 围绕跨学科框架：在科学专业知识领域内、跨领域和跨领域之间寻找， 社区智慧，确定优先事项。根据这一框架，我们召开了一次会议， 委员会由两名MPI、来自7个癌症中心的代表和SGM社区行动委员会组成， 在SGM社区组织的大力支持下，如国家LGBT癌症网络。 需要NCI R13机制（PA-21-151）的支持，以支付演讲者费用和差旅费 为受训者、早期研究者、患者和社区参与者提供服务。本次会议的目的 是：1）检查目前的证据水平，为癌症控制连续体的研究提供信息， SGM癌症患者，幸存者和护理人员; 2）确定未来癌症研究的优先事项 SGM癌症患者、幸存者和照顾者的控制连续体; 3）促进受训者的研究 和早期阶段的调查人员，特别是那些来自少数民族背景，有兴趣在整个研究 SGM社区的癌症控制连续体; 4）发展跨学科的学者网络 重点是指导和共享研究方法，可以解决癌症健康公平的问题。 癌症控制连续体; 5）传播本次会议的结果，包括未来SGM的优先事项 癌症健康公平研究，通过公开的执行摘要和同行评审，开放 访问出版物。如果获得资助，本次会议将产生：（a）SGM癌症健康权益的公开清单 研究优先事项和（B）跨学科研究人员和社区成员的网络， 就解决这些优先事项的项目进行合作。这项R13奖还将帮助我们建立一个基础设施， 未来的会议将继续这项工作，下一次会议将于2024年由Cedars Sinai在洛杉矶主办。